2326 - 2350 of 7939 Results
Title
Year
-
RESTRICTEDTitle: GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐AnalysisJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 1Start Page: 31End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13374Citation Count: 15
- How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide survey2021OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Citation Count: 5
-
RESTRICTEDTitle: The Human Tic Detector: An automatic approach to tic characterization using wearable sensorsJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 134Issue #:Start Page: 102End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2021.10.017Citation Count: 9
- White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia2021OPENTitle: White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 111Issue #:Start Page: 54End Page: 63Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.11.007Best OA location URL: http://escholarship.mcgill.ca/downloads/ns064b900Citation Count: 40
- Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue2021OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://www.nature.com/articles/s41467-021-27204-9.pdfCitation Count: 32
-
OPENTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160203Citation Count: 6
-
RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
-
RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
- Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation2021OPENTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 10
-
RESTRICTEDTitle: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and TreatmentJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,17End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94Citation Count: 0
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 65
-
OPENTitle: The contribution of behavioral features to caregiver burden in FTLD spectrum disordersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 9Start Page: 1635End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12494Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160199Citation Count: 14
-
RESTRICTEDTitle: A brief history of nearly EV‐erything – The rise and rise of extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12144Best OA location URL: http://pure-oai.bham.ac.uk/ws/files/158007662/J_of_Extracellular_Vesicle_2021_Couch_A_brief_history_of_nearly_EV_erything_The_rise_and_rise_of_extracellular.pdfCitation Count: 176
- A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding2021OPENTitle: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid BindingJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 433Issue #: 24Start Page: 167323End Page: 167323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323Best OA location URL: https://purehost.bath.ac.uk/ws/files/226493626/SI_Resubmission.pdfCitation Count: 8
-
RESTRICTEDTitle: Amantadine in the treatment of Parkinson's disease and other movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1048End Page: 1056Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00249-0Citation Count: 73
-
RESTRICTEDTitle: Autophagy and the hallmarks of agingJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 72Issue #:Start Page: 101468End Page: 101468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.arr.2021.101468Best OA location URL: http://manuscript.elsevier.com/S1568163721002154/pdf/S1568163721002154.pdfCitation Count: 115
- Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]2021RESTRICTEDTitle: Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]Journal Name: eBioMedicinePublisher: Elsevier BVVol: 74Issue #:Start Page: 103731End Page: 103731Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2021.103731Best OA location URL: http://www.thelancet.com/article/S2352396421005259/pdfCitation Count: 0
- Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories2021OPENTitle: Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratoriesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00491-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00491-yCitation Count: 34
-
RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4
- Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice2021OPENTitle: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in miceJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 2Issue #: 12Start Page: 100455End Page: 100455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xcrm.2021.100455Best OA location URL: http://www.cell.com/article/S2666379121003232/pdfCitation Count: 22
-
RESTRICTEDTitle: LRRK2 signaling in neurodegeneration: two decades of progressJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 859End Page: 872Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/ebc20210013Citation Count: 10
-
RESTRICTEDTitle: Neuropathological evidence of body-first vs. brain-first Lewy body diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 161Issue #:Start Page: 105557End Page: 105557Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105557Citation Count: 87
-
OPENTitle: Programmed autophagy prevents excess organelle baggage during neurogenesisJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 4960End Page: 4961Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.034Best OA location URL: https://doi.org/10.1016/j.molcel.2021.11.034Citation Count: 0
- Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating Scale2021OPENTitle: Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating ScaleJournal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 1Start Page: 146End Page: 158Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1044/2021_jslhr-21-00216Best OA location URL: https://doi.org/10.1044/2021_jslhr-21-00216Citation Count: 7